OrthAlign’s Multi-country Distribution Agreement with Smith & Nephew
OrthAlign entered into a multi-country distribution agreement with Smith & Nephew for its KneeAlign® Total Knee Arthroplasty component alignment technology. Feb 09, 2016
First Implantation of VGI Medical’s VerteLP Lateral Lumbar Cage with Bi-Cortical Fixation
VGI Medical announced successful implantation of the first VerteLP® Lateral Lumbar Cage. Feb 08, 2016
CollPlant Reports Final Trial Results for VergenixSTR in the Treatment of Tendinopathy
CollPlant announced positive final clinical trial results for Vergenix™STR, intended for the treatment of tendinopathy. Feb 04, 2016
Medovex Receives Reimbursement for DenerveX Facet Joint Syndrome Treatment in Germany
The German reimbursement authority released new reimbursement payment coding for the Medovex DenerveX™ system for the treatment of facet joint syndrome. Feb 04, 2016
Histogenics Completes 50% Enrollment in NeoCart Phase III Trial
Histogenics has completed >50% of the required enrollment in its ongoing NeoCart® Phase III clinical trial in the treatment of knee cartilage defects. Feb 03, 2016
Bone Therapeutics Extends Collaboration with Kasios
Bone Therapeutics extended its collaboration with Kasios to combine ALLOB® bone cell therapy with a 3D-printed synthetic cage intended to support the spinal fusion process. Feb 02, 2016
Seikagaku Ceases Development of Enthesopathy Application
Seikagaku and Kaken Pharmaceutical will discontinue development of SI-657, an additional indication of enthesopathy for the ARTZ injectable joint function-improving agent. Feb 02, 2016
BONESUPPORT Expands CERAMENT Procedure Registry
BONESUPPORT expanded its 2014 injectable bone substitute registry to include 230 CERAMENT™ G procedures, as well as procedures involving the CERAMENT V formulation. Feb 02, 2016
Amendia Launches OmegaLIF™ Expandable Interbody Cage
Amendia launched OmegaLIF™, an expandable lumbar interbody cage designed for intervertebral body spinal fusion. Feb 02, 2016
Active Implants Initiates Second Clinical Trial Evaluating NUsurface Meniscus Replacement
Active Implants initiated SUN (Safety Using NUsurface®), a 2nd clinical trial evaluating the investigational meniscus implant. Feb 02, 2016
